arrow
E

Edmund Arthur

University of Alabama at Birmingham
H指数:13
被引数:604

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and Safety of Icotrokinra, a Targeted Oral Peptide That Selectively Blocks IL-23 Receptor Activation, in Ulcerative Colitis: Results From Week 28 of ANTHEM-UC, a Phase 2b Dose-Ranging Trial

伊克罗金拉(Icotrokinra)在溃疡性结肠炎中的疗效与安全性:一项2b期剂量范围试验ANTHEM-UC第28周的结果,伊克罗金拉是一种靶向口服肽,可选择性地阻断IL-23受体激活。

2025-10-010
PRE
Use of VESsel GENeration with Optical Coherence Tomography Angiography and Fluorescein Angiography for Detection and Quantification of Vascular Changes in Mild and Moderate Diabetic Retinopathy

血管生成结合光学相干断层扫描血管造影和荧光素血管造影用于检测和量化轻度和中度糖尿病性视网膜病变的血管变化

2024-07-181
OAAI
Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK an Open-Label Phase IV Trial

依那西普在非影像学中轴型脊柱关节炎中的戒断和再治疗: 重新开始开放标签的IV期试验的结果

2022-11-154
OA
A recommended minimum data set framework for SD-OCT retinal image acquisition and analysis from the Atlas of Retinal Imaging in Alzheimer's Study (ARIAS)

从阿尔茨海默氏症研究 (ARIAS) 的视网膜成像图谱中获取和分析sd-oct视网膜图像的推荐最小数据集框架

2020-11-0115
OAAI
Disruption of cholinergic neurotransmission, within a cognitive challenge paradigm, is indicative of Aβ-related cognitive impairment in preclinical Alzheimer's disease after a 27-month delay interval

在认知挑战范式中,胆碱能神经传递的破坏表明在27个月的延迟间隔后,临床前阿尔茨海默氏病的a β 相关认知障碍

2020-03-247
OAAI
Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don and how to move forward

为阿尔茨海默病的早期阶段开发视网膜生物标志物: 我们知道什么,我们做什么以及如何前进

2020-01-08101
OAAI